Short-Term Functional, Imaging, and Electrodiagnostic Outcomes of Arthroscopic-Assisted Lower Trapezius Transfer.

Background: The purpose of this study was to evaluate the short-term functional outcomes, structural healing and neuromuscular activity after arthroscopic assisted lower trapezius transfer for irreparable posterior superior rotator cuff tears.

Methods: All patients who underwent arthroscopic assisted lower trapezius tendon transfer for an irreparable posterior superior rotator cuff tear between 2017-2021 by two surgeons with a minimum of 2 year follow-up were identified. Functional outcome scores (American Shoulder and Elbow Surgeons (ASES) score, visual analog scale (VAS) for pain), range of motion, shoulder strength, magnetic resonance imaging (MRI) to assess transfer healing and needle electromyographic (EMG) examination to assess lower trapezius muscle activity were performed at a minimum of two-years postoperatively.

Expanding pharmacist scope with an inpatient collaborative practice agreement to improve care quality and efficiency.

In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time.

Coordination in treatments for people who use anabolic androgenic steroid (AAS) - Experiences of professionals.

Research has identified the use of anabolic-androgenic steroids (AAS) as a gap between treatment needs and available facilities for substance use disorder (SUD) treatment in Norway. State policy emphasizes the need for measures to ensure coordinated treatment services. This study aims to explore whether clinical pathways of mental health and substance abuse and team-based organisation function as intended in the treatment of patients with AAS use.

De novo hepatitis B infection following liver transplantation with core antibody positive grafts: The role of surface antibody status in guiding long-term prophylaxis.

Liver transplantation (LT) with hepatitis B core antibody (anti-HBc) positive grafts to hepatitis B surface-antigen (HBsAg) negative recipients is safe and has likely contributed to improvements in organ access over the years. The incidence of de novo hepatitis B infection (HBV) in these instances is low with appropriate prophylaxis and is affected by recipient immunologic status. There is debate as to whether hepatitis B surface antibody (anti-HBs) positivity may safely inform prophylaxis discontinuation post-LT.